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rior wall + septum). left ventricular diastolic diameter (lVDD). end diastolic
and end systolic volumes (EDV, ESV) and ejection fraction were determined
in the standard fashion from 2-D echocardiograms.
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Low Current Impedance: Does It Predict Shock
Impedance in Implantable Defibrillators?
30
<47 ohms >47 ohms P value
Wall Thickness, mm 2.1 ± 0.1 2.0 ± 0.1 06
LVDD. mm 5.6 ± 0.2 6.1 ± 0.4 0.11
Mass. g 325 ± 18 338 ± 34 0.74
EDII.ml 208 ± 11 296 ± 27 0.001
ESII. ml 137 ± 10 204 ± 22 0.004
Ejection Fraction, % 35± 3 28 ± 2 016
Lead Alone. # (%) 9(30%) 4(36%) NS
Lead + Patch. # (%j 18(60%) 5(46%) NS
Required Thoracotomy. # (%) 3(10%) 2(18%) NS
Paul J. Wang. Amin Ahmad. Caroline Foote. Hassan Rastegar, Rodney Parkin, N.A.
Mark Estes III. New England Medical Center, Boston, MA; Telectronics Pacing
Systems. Sydney. Australia
The shock impedance has become increasingly important in setting the op-
timal combination of pulse width and voltage for monophasic and biphasic
shocks. However, many systems measure impedance using a 5 to 15J syn-
chronized shock in sinus rhythm. We examined the ability of a low current sig-
nal static impedance (imp) (2 mA, 15 microsec) via the shocking electrodes
to predict the impedance during shock delivery. The static impedance (mean
36.6 ± 11.1 ohms) was not statistically significant from the shock impedance
Imean 36.9 ± 8.6 ohms). The correlation (r = 0.81) of the static impedance
with the shock impedance in 83 patients during implantation of Telectronics
4210 implantable defibrillator is shown.
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Ventricular Fibrillation Induction Efficacy of Low
Energy T-Wave Synchronized Shocks in Patients
with Nonthoracotomy ICDs
Anil Bhandari. Young Park. Robert Lerman, Guo-Wen Sun, David Cannom. Good
Samaritan Hospital. Los Angeles, CA
These data suggest that the low current static impedance COrrelates well
with shock impedance and that this method may provide useful information
in setting the initial combination of pulse width and voltage, obviating the
need for a test shock in sinus rhythm.
We conclude that: (1) patients with high defibrillation lead impedance have
significantly larger EDVs and ESVs; (2) incressed impedance does not predict
need for a subcutaneous patch or inability to implant a non-thoracotomy lead
system.
Incremental ventricular pacing or alternating current have been traditionally
used to induce ventricular fibrillation (VF) while testing defibrillating function
of the ICD. The available data are limited on ventricular fibrillation induction
efficacy of the low energy T-wave shocks. To determine this, we analyzed
data in 14 patients with Medtronic ICDs (7219C 9 pts, 7219D 2 pts, PCD 3
pts) who had undergone a total of 110 VF induction attempts either at time
of ICD implant or during follow-up noninvasive EPS. The underlying heart
disease was coronary in all patients with prior myocardial infarction in 10
patients. The LV ejection fraction was 30 ± 12% (range 15-64%). aT interval
440 ± 57 ms (range 360-560 ms) and OTc interval 449 ± 49 ms (range 336-
520 ms) The low energy synchronized shocks (0.2-2J) were delivered to the
T wave of last of the 8 beat paced train at 400 ms with Sl-T delays ranging
between 290-340 ms.
Of 110 attempts with T wave shocks, the inducible arrhythmia was VF
in 69%. nonsustained polymorphic ventricular tachycardia (VT) in 15%.
monomorphic VT in 2% and none in 14%. The VF induction efficacy was
75% (69 of 92 attempts) for T-wave shock energy of >0.6J compared with
50% (9 of 18 attempts) for T-wave shock energy of ::;0.6J (P < 0.05). In con-
trast, the VF induction efficacy was unaffected by S,-T delays ranging from
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Does Monthly Fourtlme Manual Capacitor
Reformation Prolong the Lifetime of the
Implantable Cardloverter/Deflbrillator Ventak
PRX® 17oo/1705?
Factors Associated with High Impedance with a
Non-Thoracotomy Defibrillation Lead System
Michael C. Kontos. Kenneth A. Ellenbogen. Mark A. Wood. Kwame O. Akosah,
J.v. Nixon. Bruce S. Stambler. Med Coli of VA. McGuire VAMC Richmond. VA
Craig M. Pratl, Patricia S. Greenway. Mark H. Schoenfeld. Mary Lou Hibben. James
A. Reiffel. Baylor College of Medicine. Houston. Texas
In order to explore the implications of using varied definitions of sudden car-
diac death (SCD). a classification (Cl) committee (3 cardiologists) prospec-
tivelyevaluated 109 deaths over a period of 19 months in patients with an
implantable cardioverter defibriliator (ICD). The basis for Cl was the CAST
approach with additional assessments of the consequences of considering
autopsy and ICD interrogation information. Concordance andlordiscordance
between committee members was recorded. Results: Of the 834 patients
followed for 19 months. there were 109 deaths: 17 were classified SCD. 51
non-SCD. and 40 non-cardiac. Of the deaths classified as SCD, 10/17 were
unwitnessed as compared to 6151 non-SCD and 3/40 non-cardiac deaths; p
< 0.001. ICD detections occurred in 5/17 SCD <1 hour, 7/17 SCD <6 hours;
therefore. 10/17 SCD had no ICD detection or information available. There
was committee discordance in 5/17 SCD compared to 18/51 non-SCD and
16/40 non-cardiac. SCD rates as high as 3.6% (30/834) can be estimated if all
SCD cases Cl by 2:: 1 member was counted as SCD. Likewise. a SCD rate as
low as 0.8% (7/834) is possible if SCD is limited to witnessed SCD ::;1 hour;
(a 4-fold difference). Autopsy information was available in 29/1 09 deaths. In
7 cases. autopsy findings resulted in changing a "SCD" Cl (5 witnessed; 2
unwitnessed) to either non-SCD or non-cardiac [ruptured abdominal (N = 21
or thoracic aortic (N = 1) aneurysm, acute MI (N = 1), cerebral infarction
(N = 1). pulmonary embolism (N = 2)). Thus, had autopsy information been
unavailable or not considered, the SCD rate would have increased to 24/834
12.9%). ICD interrogation was unavailable in 51/109 (47%). most commonly
due to being buried with the patient or programmed off prior to death. Con-
c/usion: A 4-fold spectrum of SCD rates is possible to report from the iden-
tical data-set. ICD interrogation has significant limitations for use in death
Cl. in contrast to its utility in clinical management. Autopsy results clarify
cause-specific mortality in deaths that are temporally quite "sudden." Total
mortality is the most objective primary end point.
Background: In 2 patients the implantable cardioverter/defibrillator (ICD)
IVentak® PRx 1700/1705; Cardiac Pacemakers Inc., St. Paul) had to be re-
placed because the device fulfilled the "elective replacement time '" (ERT1)
criterion of premature battery depletion already after 601 and 756 days (d).
Study design: In 14 patients (9 with battery status "middle of life 2" (MOl2)
-the last battery status level before batterydepletion-and 5 with ERT1 we
studied prospectively, if a fourtime (instead of one) manual capacitor refor-
mation and shortening of the follow-up interval to 1 month (instead of 2) pro-
longed the battery lifetime. In addition to the battery status level the charge
time for 34 J was measured. Only if the charge time exceeded 15 s after the
second capacitor reformation, ICD replacement was scheduled.
Results: The replacement of ICDs with initial battery status ERTl was de-
layed for 163 ± 63 d. All devices with initial battery status MOl2 except 2
reached ERT1 and had to be exchanged after 960 ± 261 d. The mean charge
time decreased significantly with the second capacitor reformation (14.96
vs. 18.50 vs. 14.59 vs. 14.16 vs. 13.83 s [prior to capacitor reformation, after
1.-4. capacitor reformation]; p ::; 0.05).
Conclusion: Reaching battery status MOl2 the replacement of the ICD
Ventak® PRx 1700/1705 can be delayed at least 5 months by monthly four-
time manual capacitor reformation.
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Peak current flow across the heart determines the success of defibrillation
and is inversely dependent on the impedance between the defibrillation
electrodes. Factors associated with increased impedance with implantable
defibrillators using non-thoracotomy lead systems have not been well de-
scribed. We compared echocardiographically-derived variables in 41 patients
in whom implantation of a non-thoracotomy lead system was attempted. De-
fibrillation threshold and lead impedance were measured at end-expiration
using a monophasic shock. Patients were divided into two groups based on
impedance: low (::;47 ohms, mean 39 ± 1 ohms, N = 30) and high (>47
ohms, 51 ± 1 ohms, N = 11). left ventricular mass. wall thickness, (poste-
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